Albany, New York, October 5, 2017: The global coagulation testing market is likely to grow at a CAGR of over 9% CAGR and reach US$ 3.75 bn in revenues. According to the report, growth of the global coagulation testing market is influenced by a host of factors, prime among them being the increasing emphasis on early detection of blood clotting disorders. These insights are according to a new report added to the repository of Market Research Reports Search Engine (MRRSE). The report titled “Coagulation Testing Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025” offers comprehensive insights on the future direction of coagulation testing market.
According to the report, coagulation testing is being emphasized heavily in healthcare settings in many developing countries. Coagulation testing remains a reliable source of detecting inherited and acquired bleeding disorders. Increase in the prevalence of bleeding disorders has also contributed to higher rates of coagulation testing.
In a bid to offer comprehensive insights and analysis to readers, the report offers detailed segmentation on a number of parameters. According to the report, the global coagulation testing market is segmented into instruments and consumables on the basis of product type. Consumables currently account for bulk of the demand, accounting for as much as 80% revenue share of the market. By test type, PT test segment remains widely used, accounting for nearly 70% revenue share by test type.
Diagnostic laboratories remain the largest end-users of coagulation testing. Demand for coagulation testing from diagnostic laboratories is likely to grow at over 10% CAGR during the forecast period.
North America and Europe remain two lucrative markets for coagulation testing, owing to increasing spending on healthcare products and services. According to the report, the per capita spending on healthcare is higher in many countries in Europe as compared to APAC and Latin America, and this will continue to influence the market favourably during the forecast period.
Although North America and Europe will remain lucrative markets for coagulation testing, accounting for as much as US$ 1 bn in revenues by 2025, opportunities abound in the APAC market. Although still at a nascent stage, the market in APAC is likely to offer a multitude of opportunities to manufacturers during the forecast period.
The leading players in the global coagulation testing market include F. Hoffmann-La Roche Ltd., Universal Biosensors, Inc., Abbott Laboratories, SYSMEX CORPORATION, Alere Inc., Helena Laboratories, Inc. Siemens Healthineers, HemoSonics, LLC.
Browse Full Global Coagulation Testing Market Report with TOC : https://www.mrrse.com/coagulation-testing-market
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY – 12207